Non-Cochrane · DTA · PM42774089

Diagnostic performance of artificial intelligence in oral squamous cell carcinoma detection: a higher-order evidence synthesis through umbrella review and meta-meta-analysis.

Jodalli Praveen, Vinay Vineet, Chavan Mahesh, et al. · Frontiers in dental medicine · 2026 · PubMed · doi:10.3389/fdmed.2026.1915105

Findings

9 findings

Population
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesArtificial intelligence (machine and deep learning) diagnostic models, any image modalityHistopathological diagnosis (biopsy/surgical specimen) as reference standardImplementation feasibility (cost-effectiveness, workflow integration)
Any clinical setting; no geographic restriction
Implementation feasibility: Qualitative evidence only; No. of reviews (primary studies): 7 (Mixed); Very Low; Major barriers identified; minimal real-world implementation
Very low
Downgraded: imprecision, indirectness
7 studies
People evaluated for OSCCAI diagnostic systemsHistopathological diagnosisSensitivitySensitivity 0.90 [0.81, 0.99]
GRADE not reported
6 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesHistopathology-based AI (whole slide images, tissue microarrays)Histopathological diagnosis (biopsy/surgical specimen) as reference standardSensitivity for OSCC detection
Any clinical setting; no geographic restriction
Sensitivity 0.87 [0.82, 0.91]
87 [82, 91] per 100 patients with OSCC correctly identified
Moderate
Downgraded: inconsistency
9 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesHistopathology-based AI (whole slide images, tissue microarrays)Histopathological diagnosis (biopsy/surgical specimen) as reference standardSpecificity for OSCC detection
Any clinical setting; no geographic restriction
Specificity 0.86 [0.81, 0.90]
86 [81, 90] per 100 patients without OSCC correctly identified
Moderate
Downgraded: inconsistency
9 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesClinical photography-based AIHistopathological diagnosis (biopsy/surgical specimen) as reference standardSpecificity for OSCC detection
Any clinical setting; no geographic restriction
Specificity 0.85 [0.80, 0.89]
85 [80, 89] per 100 patients without OSCC correctly identified
Low
Downgraded: imprecision, inconsistency
6 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesClinical photography-based AIHistopathological diagnosis (biopsy/surgical specimen) as reference standardSensitivity for OSCC detection
Any clinical setting; no geographic restriction
Sensitivity 0.87 [0.83, 0.90]
87 [83, 90] per 100 patients with OSCC correctly identified
Low
Downgraded: imprecision, inconsistency
6 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesOptical coherence tomography (OCT)-based AIHistopathological diagnosis (biopsy/surgical specimen) as reference standardSpecificity for OSCC detection
Any clinical setting; no geographic restriction
Specificity 0.88 [0.82, 0.93]
88 [82, 93] per 100 patients without OSCC correctly identified
Very low
Downgraded: imprecision, indirectness
3 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesOptical coherence tomography (OCT)-based AIHistopathological diagnosis (biopsy/surgical specimen) as reference standardSensitivity for OSCC detection
Any clinical setting; no geographic restriction
Sensitivity 0.90 [0.85, 0.94]
90 [85, 94] per 100 patients with OSCC correctly identified
Very low
Downgraded: imprecision, indirectness
3 studies
Patients with oral lesions assessed for oral squamous cell carcinoma (OSCC); evidence from systematic reviews of diagnostic accuracy studiesHistopathology-based AIClinical photography-based AIDiagnostic odds ratio for OSCC detection
Any clinical setting; no geographic restriction
Ratio of diagnostic odds ratios 2.15 [1.42, 3.26]
Low
15 studies

Included primary studies 15

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Kim 2022
Efficacy of Artificial Intelligence-Assisted Discrimination of Oral Cancerous Lesions from Normal Mucosa Based on the Oral Mucosal Image:…
PMID:35884560
20222 other reviewsnot statednot extracted yet
Li 2024
Diagnostic accuracy of artificial intelligence assisted clinical imaging in the detection of oral potentially malignant disorders and oral…
PMID:38652301
20242 other reviewsnot statednot extracted yet
Elmakaty 2022
Accuracy of artificial intelligence-assisted detection of Oral Squamous Cell Carcinoma: A systematic review and meta-analysis.
PMID:35931404
20221 other reviewnot statednot extracted yet
Sahoo 2024
Diagnostic performance of artificial intelligence in detecting oral potentially malignant disorders and oral cancer using medical…
PMID:39568787
20241 other reviewnot statednot extracted yet
Alabi 2021
Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.
PMID:31422502
2019this review onlynot statednot extracted yet
Chowdhury 2025
Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review.
PMID:40330404
2025this review onlynot statednot extracted yet
Jerjes 2024
Enhancing Oral Cancer Detection: A Systematic Review of the Diagnostic Accuracy and Future Integration of Optical Coherence Tomography…
PMID:39407882
2024this review onlynot statednot extracted yet
Khanagar 2021
Application and Performance of Artificial Intelligence Technology in Oral Cancer Diagnosis and Prediction of Prognosis: A Systematic Review.
PMID:34072804
2021this review onlynot statednot extracted yet
Khanagar 2023
Application and Performance of Artificial Intelligence (AI) in Oral Cancer Diagnosis and Prediction Using Histopathological Images: A…
PMID:37371706
2023this review onlynot statednot extracted yet
Mahmood 2020
Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review.
PMID:32674040
2020this review onlynot statednot extracted yet
Malhotra 2024
Diagnostic Accuracy of Artificial Intelligence Compared to Biopsy in Detecting Early Oral Squamous Cell Carcinoma: A Systematic Review and…
PMID:39205556
2024this review onlynot statednot extracted yet
Nieri 2025
Diagnosis of Oral Cancer With Deep Learning. A Comparative Test Accuracy Systematic Review.
PMID:40163741
2025this review onlynot statednot extracted yet
Pirayesh 2024
Deep Learning-Based Image Classification and Segmentation on Digital Histopathology for Oral Squamous Cell Carcinoma: A Systematic Review…
PMID:39256895
2024this review onlynot statednot extracted yet
Ren 2025
The diagnostic value of artificial intelligence in oral squamous cell carcinoma: A systematic review and meta-analysis.
PMID:40518015
2025this review onlynot statednot extracted yet
Thakuria 2024
Deep learning for early diagnosis of oral cancer via smartphone and DSLR image analysis: a systematic review.
PMID:39587051
2024this review onlynot statednot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationSystematic reviews and/or meta-analyses on diagnosis of histologically confirmed OSCC in humans (OPMD reviews only with separate OSCC data)15 systematic reviews (2020 to 2025) synthesizing 341 primary study inclusions (about 241 unique primary studies; CCA 9.06%)
InterventionAny AI-based diagnostic technology (traditional machine learning, deep learning, hybrid models) on histopathology, clinical photographs, OCT, autofluorescence, cytology, radiography or hyperspectral imagingAI on histopathology (n=9 reviews), clinical photography (n=6), OCT (n=3), mixed/other modalities (n=5); deep learning in 12 reviews
ComparisonHistopathological diagnosis (biopsy or surgical specimen) as reference standard; expert clinical examination or conventional non-AI methodsHistopathology reference standard; clinical photography-based AI as comparator for histopathology-based AI (relative DOR)
OutcomesPrimary: sensitivity, specificity, DOR, AUC, PLR/NLR. Secondary: clinical utility, implementation feasibility, economic evaluations, barriers to adoptionPooled sensitivity by meta-meta-analysis (n=6 reviews); GRADE SoF for sensitivity and specificity by modality (histopathology n=9, clinical photography n=6, OCT n=3), relative DOR (n=15), implementation feasibility (n=7, qualitative); specificity not pooled by meta-meta-analysis
Study designsCompleted peer-reviewed systematic reviews and/or meta-analyses with search of at least two databasesSystematic reviews only (n=7) and systematic reviews with meta-analysis (n=8)
TimingNot specifiedNot specified